JP2024514935A5 - - Google Patents
Info
- Publication number
- JP2024514935A5 JP2024514935A5 JP2023564409A JP2023564409A JP2024514935A5 JP 2024514935 A5 JP2024514935 A5 JP 2024514935A5 JP 2023564409 A JP2023564409 A JP 2023564409A JP 2023564409 A JP2023564409 A JP 2023564409A JP 2024514935 A5 JP2024514935 A5 JP 2024514935A5
- Authority
- JP
- Japan
- Prior art keywords
- frα
- composition according
- subject
- less
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP2021/060749 WO2021214329A1 (en) | 2020-04-24 | 2021-04-23 | Composition comprising an ige antibody |
| EPPCT/EP2021/060749 | 2021-04-23 | ||
| GB2109550.0 | 2021-07-01 | ||
| GBGB2109550.0A GB202109550D0 (en) | 2021-07-01 | 2021-07-01 | Composition |
| PCT/EP2022/060693 WO2022223784A1 (en) | 2021-04-23 | 2022-04-22 | Composition comprising an ige antibody |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024514935A JP2024514935A (ja) | 2024-04-03 |
| JP2024514935A5 true JP2024514935A5 (https=) | 2025-04-18 |
Family
ID=81750377
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023564409A Pending JP2024514935A (ja) | 2021-04-23 | 2022-04-22 | ＩｇＥ抗体を含む組成物 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240190955A1 (https=) |
| EP (1) | EP4326770A1 (https=) |
| JP (1) | JP2024514935A (https=) |
| KR (1) | KR20240001136A (https=) |
| AU (1) | AU2022263376A1 (https=) |
| BR (1) | BR112023021873A2 (https=) |
| CA (1) | CA3215850A1 (https=) |
| MX (1) | MX2023012557A (https=) |
| WO (1) | WO2022223784A1 (https=) |
| ZA (1) | ZA202309456B (https=) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4458066A (en) | 1980-02-29 | 1984-07-03 | University Patents, Inc. | Process for preparing polynucleotides |
| US5807715A (en) | 1984-08-27 | 1998-09-15 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| US5565332A (en) | 1991-09-23 | 1996-10-15 | Medical Research Council | Production of chimeric antibodies - a combinatorial approach |
| TWI622402B (zh) | 2010-02-24 | 2018-05-01 | 免疫遺傳股份有限公司 | 葉酸受體１抗體類和免疫共軛物類及彼等之用途 |
| EP2764025B1 (en) | 2011-10-04 | 2017-11-29 | IGEM Therapeutics Limited | Ige-antibodies against hmw-maa |
| US20180333503A1 (en) | 2017-05-16 | 2018-11-22 | Immunogen, Inc. | Anti-folr1 immunoconjugates and anti-pd-1 antibody combinations |
| GB202006093D0 (en) * | 2020-04-24 | 2020-06-10 | King S College London | Composition |
-
2022
- 2022-04-22 BR BR112023021873A patent/BR112023021873A2/pt unknown
- 2022-04-22 AU AU2022263376A patent/AU2022263376A1/en active Pending
- 2022-04-22 US US18/287,623 patent/US20240190955A1/en active Pending
- 2022-04-22 WO PCT/EP2022/060693 patent/WO2022223784A1/en not_active Ceased
- 2022-04-22 MX MX2023012557A patent/MX2023012557A/es unknown
- 2022-04-22 JP JP2023564409A patent/JP2024514935A/ja active Pending
- 2022-04-22 EP EP22724722.8A patent/EP4326770A1/en active Pending
- 2022-04-22 CA CA3215850A patent/CA3215850A1/en active Pending
- 2022-04-22 KR KR1020237035816A patent/KR20240001136A/ko active Pending
-
2023
- 2023-10-10 ZA ZA2023/09456A patent/ZA202309456B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA128202C2 (uk) | Стабільна композиція антитіла до рецептора програмованої загибелі 1 (pd-1) і спосіб її застосування | |
| JP2007515469A5 (https=) | ||
| JP2015163635A (ja) | Ｌ−オルニチンフェニル酢酸塩を用いる門脈圧亢進の治療及び肝機能の修復 | |
| JPH03188021A (ja) | レトロウイルスを撲滅するための医薬品およびその製造法 | |
| WO2015090162A1 (zh) | 一种含有阿达木单抗的药物组合物 | |
| JP2017533274A (ja) | メトトレキサート製剤 | |
| CN103877101A (zh) | 葫芦素在制备抗肿瘤药物中的应用 | |
| US20190241660A1 (en) | Immune-stimulating peptides and checkpoint inhibitors, and uses thereof for treating cancer | |
| US11974993B2 (en) | Solution formulations of CX-011 | |
| SK129999A3 (en) | Pharmaceutical composition, preparation process and use thereof | |
| US9919053B2 (en) | Cabazitaxel composition | |
| JP2024514935A5 (https=) | ||
| US12533373B2 (en) | β-glucan composition and use therefor | |
| CN110327466A (zh) | 用于治疗肝纤维化的药物组合物及其应用 | |
| CN111393278B (zh) | 一种长松萝衍生物及其在制备治疗胆囊癌药物中的用途 | |
| TWI822897B (zh) | 一種抗pd-1抗體和法米替尼聯合在製備治療腫瘤的藥物中的用途 | |
| WO2005030149A2 (en) | Suppression of hiv replication for prevention and treatment of hiv | |
| JPS6310685B2 (https=) | ||
| CN113082203B (zh) | 一种免疫抑制剂单克隆抗体的液体制剂 | |
| WO2019114125A1 (en) | A novel quinochalcone compound and uses thereof for treating cancer or inflammation | |
| US20250049869A1 (en) | Use of auricularia auricula total polysaccharide or monomeric polysaccharide in preparation of pd-l1 inhibitor | |
| CN104740630A (zh) | 一种含有抗cd52单抗的药物组合物 | |
| CN111728960B (zh) | 富马酸比索洛尔联合多西他赛在制备抗肿瘤药物中的应用 | |
| JPS6213922B2 (https=) | ||
| CN111065405A (zh) | 口服生物利用度高的聚乙二醇化干扰素λ及其制备方法 |